Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Veronika Bachanova, MD, Dhifaf Sarhan, PhD, Todd E. DeFor, MS, Sarah Cooley, MD, Angela Panoskaltsis-Mortari, PhD, Michael R. Verneris, MD, Bruce R. Blazar, MD, Julie Curtsinger, PhD, Linda J. Burns, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2016) 128 (22): 3030.

https://doi.org/10.1182/blood.V128.22.3030.3030

Published: 2016

Journal Articles

Fewer Circulating Natural Killer Cells 28 Days after Double Cord Blood Transplantation (dUCBT) Predicts Inferior Survival and IL-15 Response

Bergerson Rachel, PhD, Robin Williams, MD MS, Hongbo Wang, MD PhD, Ryan Shanley, MS, Gretchen Hoff, Alyssa Kerber, Sarah Cooley, MD, Julie Curtsinger, PhD, Martin Felices, PhD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2231.

https://doi.org/10.1182/blood.V128.22.2231.2231

Published: 2016

Journal Articles

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Lucie M. Turcotte, MD, Qing Cao, MS, Elias Krahn, Julie Curtsinger, PhD, Ashley M. Yingst, MS, Sarah Cooley, MD, Claudio G Brunstein, MD, Margaret L. MacMillan, MD, Shernan G. Holtan, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2232.

https://doi.org/10.1182/blood.V128.22.2232.2232

Published: 2016

Journal Articles

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, M.S., Rohtesh S. Mehta, MD MPH, MS, Xianghua Luo, PhD, Julie Curtsinger, PhD, Sarah Cooley, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, John E. Wagner, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 4590.

https://doi.org/10.1182/blood.V128.22.4590.4590

Published: 2016

Journal Articles

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

Mayada Salman Abu Shanap, MD, Sarah Cooley, MD, Xianghua Luo, PhD, Cao Qing, Julie Curtsinger, PhD, Rachel Bergerson, PhD, Nelli Bejanyan, Heather Stefanski, MD PhD, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E Wagner, MD, Michael R. Verneris, MD

Blood (2015) 126 (23): 1934.

https://doi.org/10.1182/blood.V126.23.1934.1934

Published: 2015

Journal Articles

A Phase I Study of Intravenous NCI IL-15 to Enhance Adoptively Transferred NK Cells Uncovers Defects in CD16 Triggered IFNγ Production and Competition Between Donor NK and Recipient T Cells

Jeffrey S. Miller, MD, Michael R. Verneris, MD, Julie Curtsinger, PhD, Todd E. DeFor, MS, David McKenna, MD, Thomas A Waldmann, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, Sarah Cooley, MD

Blood (2015) 126 (23): 566.

https://doi.org/10.1182/blood.V126.23.566.566

Published: 2015

Journal Articles

Preliminary Results of a Phase 1/2 Clinical Trial of Cndo-109-Activated Allogeneic Natural Killer Cells in High Risk Acute Myelogenous Leukemia Patients in First Complete Remission

Todd A. Fehniger, MD PhD, Robert K Stuart, MD, Sarah A. Cooley, MD MS, Jeffrey S. Miller, MD, Julie Curtsinger, PhD, Timothy Mark Hillman, MSc, Nova Silver, RN, Michael Szarek, PhD, Mark W Lowdell, BSc, MSc, PhD FRCPath, Leonid Gorelik, PhD, Eric Rowinsky, MD

Blood (2014) 124 (21): 2320.

https://doi.org/10.1182/blood.V124.21.2320.2320

Published: 2014

Journal Articles

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Rachel Joy Bergerson, PhD, Sarah Cooley, MD, Julie Curtsinger, PhD, Ryan Shanley, Claudio Brunstein, MD, Bruce R Blazar, MD, John E. Wagner, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2013) 122 (21): 4610.

https://doi.org/10.1182/blood.V122.21.4610.4610

Published: 2013

Journal Articles

Functional NK Cell Repertoires Are Determined By Survival Mechanisms Through IL-2Ra and FasL

Martin Felices, PhD, Todd Lenvik, Dave Ankarlo, Bree Foley, PhD, Julie Curtsinger, PhD, Bruce R Blazar, MD, Stephen K Anderson, Ph.D., Jeffrey S. Miller, MD

Blood (2013) 122 (21): 786.

https://doi.org/10.1182/blood.V122.21.786.786

Published: 2013

Journal Articles

Optimal Xenogeneic Adoptive Transfer of Human NK Cells: Fresh NK Cells and IL-15 Administration Are Superior to Frozen NK Cells and IL-2

Jakub Tolar, MD, PhD, Julie Curtsinger, PhD, Ron McElmurry, Valarie McCullar, Michael R. Verneris, MD, Frits van Rhee, MD, PhD, Natalia Lapteva, Cliona M Rooney, PhD, John E. Wagner, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 346.

https://doi.org/10.1182/blood.V120.21.346.346

Published: 2012

Journal Articles

Education and Cytokine Receptor Balance Play a Critical Role in Long Term Survival of the Most Differentiated Natural Killer (NK) Cells.

Martin Felices, PhD, Todd Lenvik, Dave Ankarlo, Julie Curtsinger, PhD, Jakub Tolar, MD, PhD, Bruce R. Blazar, MD, Stephen Anderson, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 2148.

https://doi.org/10.1182/blood.V120.21.2148.2148

Published: 2012

Journal Articles

Recombinant Human IL-15 Promotes in Vivo Expansion of Adoptively Transferred NK Cells in a First-in-Human Phase I Dose Escalation Study in Patients with AML

Sarah Cooley, MD, Michael R. Verneris, MD, Julie Curtsinger, PhD, David McKenna, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Thomas A Waldmann, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 894.

https://doi.org/10.1182/blood.V120.21.894.894

Published: 2012

Journal Articles

Natural Killer (NK) Cells Respond to CMV Reactivation After Allogeneic Transplantation with An Increase in NKG2C + CD57 + Self-KIR + NK Cells with Potent IFNγ Production

Bree Foley, PhD, Michael R Verneris, MD, Julie Curtsinger, PhD, Sandra Lopez-Verges, Lewis L. Lanier, PhD, Daniel J. Weisdorf, MD, Sarah Cooley, MD, Jeffrey S. Miller, MD

Blood (2011) 118 (21): 356.

https://doi.org/10.1182/blood.V118.21.356.356

Published: 2011

Journal Articles

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

Sarah Cooley, MD, John E. Wagner, MD, Claudio Brunstein, MD, Mie Hagiwara, Giordi Orreggio, Julie Curtsinger, PhD, Todd Defor, Xianghua Luo, Bruce R. Blazar, MD, Phillip McGlave, MD, Jeffrey S. Miller, MD, Michael R Verneris, MD

Blood (2010) 116 (21): 3731.

https://doi.org/10.1182/blood.V116.21.3731.3731

Published: 2010

Journal Articles

NK Education: Disassociation Between Recovery of Cytoxicity and Cytokine Production In NK Cells After Allogeneic Transplantation.

Bree Foley, PhD, Sarah Cooley, MD, Julie Curtsinger, PhD, Michael Verneris, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2010) 116 (21): 1462.

https://doi.org/10.1182/blood.V116.21.1462.1462

Published: 2010

Journal Articles

Defective Neo-Antigen Response to Keyhole Limpet Hemocyanin (KLH) Vaccines in Patients after Hematopoietic Cell Transplantation.

Jeffrey S. Miller, MD, Julie Curtsinger, PhD, Kirsten Malvey, Susan K. Fautsch, Arkadiusz Dudek, MD, Bruce R. Blazar, MD, Angela Panoskaltsis-Mortari, PhD

Blood (2004) 104 (11): 2229.

https://doi.org/10.1182/blood.V104.11.2229.2229

Published: 2004

NARROW

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Fewer Circulating Natural Killer Cells 28 Days after Double Cord Blood Transplantation (dUCBT) Predicts Inferior Survival and IL-15 Response

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

A Phase I Study of Intravenous NCI IL-15 to Enhance Adoptively Transferred NK Cells Uncovers Defects in CD16 Triggered IFNγ Production and Competition Between Donor NK and Recipient T Cells

Preliminary Results of a Phase 1/2 Clinical Trial of Cndo-109-Activated Allogeneic Natural Killer Cells in High Risk Acute Myelogenous Leukemia Patients in First Complete Remission

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Functional NK Cell Repertoires Are Determined By Survival Mechanisms Through IL-2Ra and FasL

Optimal Xenogeneic Adoptive Transfer of Human NK Cells: Fresh NK Cells and IL-15 Administration Are Superior to Frozen NK Cells and IL-2

Education and Cytokine Receptor Balance Play a Critical Role in Long Term Survival of the Most Differentiated Natural Killer (NK) Cells.

Recombinant Human IL-15 Promotes in Vivo Expansion of Adoptively Transferred NK Cells in a First-in-Human Phase I Dose Escalation Study in Patients with AML

Natural Killer (NK) Cells Respond to CMV Reactivation After Allogeneic Transplantation with An Increase in NKG2C + CD57 + Self-KIR + NK Cells with Potent IFNγ Production

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

NK Education: Disassociation Between Recovery of Cytoxicity and Cytokine Production In NK Cells After Allogeneic Transplantation.

Defective Neo-Antigen Response to Keyhole Limpet Hemocyanin (KLH) Vaccines in Patients after Hematopoietic Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only